Kensuke Komatsu

Lack of cross‐resistance to FF‐10501, an inhibitor of inosine‐5′‐monophosphate dehydrogenase, in azacitidine‐resistant cell lines selected from SKM‐1 and MOLM‐13 leukemia cell lines

Y. Shimada, T. Maekawa, Takaaki Nakamura, 2016, Pharmacology research & perspectives.

Molecular targeting of inosine-5’-monophosphate dehydrogenase by FF-10501 promotes erythropoiesis via ROS/MAPK pathway

Y. Kanakura, K. Oritani, M. Ichii, 2018, Leukemia & lymphoma.

IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia

T. Shibata, S. Yamasaki, A. Sasaki, 2022, EMBO molecular medicine.